| Revenue | {{ Info.Revenue | formatUSD }} |
| Headquarters | {{ Info.Headquarters }} |
| As of Date | 03/28/2025 |
| Adviser Type - Large advisory firm | |
| Number of Employees | 8 14.29% |
| of those in investment advisory functions | 7 16.67% |
| Registration | SEC, Approved, 12/19/2003 |
| AUM* | 537,691,399 -0.93% |
| of that, discretionary | 537,691,399 -0.93% |
| Private Fund GAV* | 537,691,400 -58.37% |
| Avg Account Size | 134,422,850 -0.93% |
| SMA’s | No |
| Private Funds | 6 |
| Contact Info | 310 xxxxxxx |
| Websites |
- Pooled investment vehicles
- Portfolio management for pooled investment vehicles
- A percentage of assets under your management
- Performance-based fees
| Fund Type | Count | GAV |
|---|---|---|
| Fund TypeHedge Fund | Count6 | GAV$537,691,400 |
| Adviser | Hedge Fund | Liquidity Fund | Private Equity Fund | Real Estate Fund | Securitized Asset Fund | Venture Capital Fund | Other Fund | Total Private Fund GAV | AUM | #Funds | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Adviser AR ASSET MANAGEMENT, INC. | Hedge Fund154.0m | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund- | Other Fund- | Total Private Fund GAV154.0m | AUM573.2m | #Funds3 | |
| Adviser FORT, L.P. | Hedge Fund93.1m | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund- | Other Fund- | Total Private Fund GAV93.1m | AUM397.2m | #Funds6 | |
| Adviser ENGLE CAPITAL MANAGEMENT, L.P. | Hedge Fund465.2m | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund- | Other Fund- | Total Private Fund GAV465.2m | AUM572.5m | #Funds3 | |
| Adviser LOGAN STONE | Hedge Fund435.3m | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund- | Other Fund- | Total Private Fund GAV435.3m | AUM513.1m | #Funds2 | |
| Adviser SHAH CAPITAL MANAGEMENT | Hedge Fund558.2m | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund- | Other Fund- | Total Private Fund GAV558.2m | AUM639.3m | #Funds1 | |
| Adviser ORIBEL CAPITAL MANAGEMENT, LP | Hedge Fund119.2m | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund- | Other Fund- | Total Private Fund GAV119.2m | AUM1.7b | #Funds3 | |
| Adviser INCOME PARTNERS ASSET MANAGEMENT (HK) LIMITED | Hedge Fund- | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund- | Other Fund- | Total Private Fund GAV- | AUM368.3m | #Funds- | |
| Adviser SOLAS CAPITAL MANAGEMENT, LLC | Hedge Fund89.7m | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund- | Other Fund- | Total Private Fund GAV89.7m | AUM599.4m | #Funds2 | |
| Adviser RIVA RIDGE CAPITAL MANAGEMENT LP | Hedge Fund653.1m | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund- | Other Fund- | Total Private Fund GAV653.1m | AUM694.7m | #Funds10 | |
| Adviser KEENAN CAPITAL, LLC | Hedge Fund691.8m | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund- | Other Fund- | Total Private Fund GAV691.8m | AUM691.8m | #Funds1 |
| Stock Ticker | Stock Name | $ Position | % Position | $ Change | # Change |
|---|---|---|---|---|---|
| Stck Ticker78464A870 | Stock NameSPDR S&P BIOTECH ETF | $ Position$35,799,300 | % Position9.00% | $ Change-10.00% | # Change-1.00% |
| Stck Ticker85916J409 | Stock NameSTEREOTAXIS INC | $ Position$31,191,663 | % Position8.00% | $ Change12.00% | # Change0.00% |
| Stck Ticker76155X100 | Stock NameREVOLUTION MEDICINES INC | $ Position$27,607,638 | % Position7.00% | $ Change18.00% | # Change22.00% |
| Stck TickerN5749R100 | Stock NameMERUS N V | $ Position$18,998,358 | % Position5.00% | $ Change-8.00% | # Change10.00% |
| Stck Ticker23282W605 | Stock NameCYTOKINETICS INC | $ Position$18,726,624 | % Position5.00% | $ Change-11.00% | # Change0.00% |
| Stck Ticker04963C209 | Stock NameATRICURE INC | $ Position$19,609,527 | % Position5.00% | $ Change9.00% | # Change0.00% |
| Stck Ticker04351P101 | Stock NameASCENDIS PHARMA A/S | $ Position$14,228,883 | % Position4.00% | $ Change6.00% | # Change15.00% |
| Stck Ticker05463X106 | Stock NameAXOGEN INC | $ Position$13,956,615 | % Position4.00% | $ Change6.00% | # Change-10.00% |
| Stck Ticker09627Y109 | Stock NameBLUEPRINT MEDICINES CORP | $ Position$13,062,329 | % Position3.00% | $ Change16.00% | # Change23.00% |
| Stck Ticker464287556 | Stock NameISHARES NASDAQ BIOTECH INDX | $ Position$13,551,525 | % Position3.00% | $ Change-9.00% | # Change0.00% |